Works by Schuler, Martin


Results: 150
    1

    Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform.

    Published in:
    EMBO Molecular Medicine, 2025, v. 17, n. 6, p. 1203, doi. 10.1038/s44321-025-00229-z
    By:
    • Schuler, Martin;
    • Gerwert, Grischa;
    • Mann, Marvin;
    • Woitzik, Nathalie;
    • Langenhoff, Lennart;
    • Hubert, Diana;
    • Duman, Deniz;
    • Höveler, Adrian;
    • Galkowski, Sandy;
    • Simon, Jonas;
    • Denz, Robin;
    • Weber, Sandrina;
    • Kwon, Eun-Hae;
    • Wanka, Robin;
    • Kötting, Carsten;
    • Güldenhaupt, Jörn;
    • Beyer, Léon;
    • Tönges, Lars;
    • Mollenhauer, Brit;
    • Gerwert, Klaus
    Publication type:
    Article
    2

    Structure of the ribosome-bound cricket paralysis virus IRES RNA.

    Published in:
    Nature Structural & Molecular Biology, 2006, v. 13, n. 12, p. 1092, doi. 10.1038/nsmb1177
    By:
    • Schüler, Martin;
    • Connell, Sean R.;
    • Lescoute, Aurelie;
    • Giesebrecht, Jan;
    • Dabrowski, Marylena;
    • Schroeer, Birgit;
    • Mielke, Thorsten;
    • Penczek, Pawel A.;
    • Westhof, Eric;
    • Spahn, Christian M. T.
    Publication type:
    Article
    3
    4
    5

    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

    Published in:
    2018
    By:
    • Wu, Yi-Long;
    • Sequist, Lecia V;
    • Tan, Eng-Huat;
    • Geater, Sarayut L;
    • Orlov, Sergey;
    • Zhang, Li;
    • Lee, Ki Hyeong;
    • Tsai, Chun-Ming;
    • Kato, Terufumi;
    • Barrios, Carlos H;
    • Schuler, Martin;
    • Hirsh, Vera;
    • Yamamoto, Nobuyuki;
    • O'Byrne, Kenneth;
    • Boyer, Michael;
    • Mok, Tony;
    • Peil, Barbara;
    • Märten, Angela;
    • Chih-Hsin Yang, James;
    • Paz-Ares, Luis
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12

    Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1389-4
    By:
    • Pöttgen, Christoph;
    • Stuschke, Martin;
    • Graupner, Britta;
    • Theegarten, Dirk;
    • Gauler, Thomas;
    • Jendrossek, Verena;
    • Freitag, Lutz;
    • Abu Jawad, Jehad;
    • Gkika, Eleni;
    • Wohlschlaeger, Jeremias;
    • Welter, Stefan;
    • Hoiczyk, Matthias;
    • Schuler, Martin;
    • Stamatis, Georgios;
    • Eberhardt, Wilfried
    Publication type:
    Article
    13
    14

    Perfusion settings and additives in liver normothermic machine perfusion with red blood cells as oxygen carrier. A systematic review of human and porcine perfusion protocols.

    Published in:
    Transplant International, 2018, v. 31, n. 9, p. 956, doi. 10.1111/tri.13306
    By:
    • Eshmuminov, Dilmurodjon;
    • Leoni, Filippo;
    • Schneider, Marcel André;
    • Muller, Xavier;
    • Dutkowski, Philipp;
    • Graf, Rolf;
    • Clavien, Pierre‐Alain;
    • Bautista Borrego, Lucia;
    • Becker, Dustin;
    • Hefti, Max;
    • Schuler, Martin J.;
    • Onder, Christopher;
    • Rudolf von Rohr, Philipp
    Publication type:
    Article
    15

    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 9243, doi. 10.1007/s00432-023-04839-3
    By:
    • Kraskowski, Oliver;
    • Stratmann, Jan A.;
    • Wiesweg, Marcel;
    • Eberhardt, Wilfried;
    • Metzenmacher, Martin;
    • Schmid, Kurt W.;
    • Herold, Thomas;
    • Schildhaus, Hans-Ulrich;
    • Darwiche, Kaid;
    • Aigner, Clemens;
    • Stuschke, Martin;
    • Laue, Katharina;
    • Zaun, Gregor;
    • Kasper, Stefan;
    • Hense, Jörg;
    • Sebastian, Martin;
    • Schuler, Martin;
    • Pogorzelski, Michael
    Publication type:
    Article
    16

    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4315, doi. 10.1007/s00432-022-04314-5
    By:
    • Rosery, Vivian;
    • Mika, Stephan;
    • Schmid, Kurt Werner;
    • Reis, Henning;
    • Stuschke, Martin;
    • Treckmann, Jürgen;
    • Markus, Peter;
    • Schumacher, Brigitte;
    • Albers, David;
    • Mende, Bastian;
    • Lahner, Harald;
    • Wiesweg, Marcel;
    • Schuler, Martin;
    • Siveke, Jens T.;
    • Kasper, Stefan
    Publication type:
    Article
    17

    Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 6, p. 1559, doi. 10.1007/s00432-020-03184-z
    By:
    • Welt, Anja;
    • Bogner, Simon;
    • Arendt, Marina;
    • Kossow, Josef;
    • Huffziger, Antonia;
    • Pohlkamp, Christian;
    • Steiniger, Heike;
    • Becker, Ute;
    • Alashkar, Ferras;
    • Kohl, Marzena;
    • Wiesweg, Marcel;
    • Richly, Heike;
    • Hense, Jörg;
    • Scheulen, Max E.;
    • Schuler, Martin;
    • Seeber, Siegfried;
    • Tewes, Mitra
    Publication type:
    Article
    18

    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
    By:
    • Schuler, Martin;
    • Tan, Eng-Huat;
    • O'Byrne, Kenneth;
    • Zhang, Li;
    • Boyer, Michael;
    • Mok, Tony;
    • Hirsh, Vera;
    • Yang, James Chih-Hsin;
    • Lee, Ki Hyeong;
    • Lu, Shun;
    • Shi, Yuankai;
    • Kim, Sang-We;
    • Laskin, Janessa;
    • Kim, Dong-Wan;
    • Arvis, Catherine Dubos;
    • Kölbeck, Karl;
    • Massey, Dan;
    • Märten, Angela;
    • Paz-Ares, Luis;
    • Park, Keunchil
    Publication type:
    Article
    19
    20
    21

    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 4, p. 795, doi. 10.1007/s00432-015-2095-y
    By:
    • Köhler, Jens;
    • Schuler, Martin;
    • Gauler, Thomas;
    • Nöpel-Dünnebacke, Stefanie;
    • Ahrens, Maike;
    • Hoffmann, Andreas-Claudius;
    • Kasper, Stefan;
    • Nensa, Felix;
    • Gomez, Benedikt;
    • Hahnemann, Maria;
    • Breitenbuecher, Frank;
    • Cheufou, Danjouma;
    • Özkan, Filiz;
    • Darwiche, Kaid;
    • Hoiczyk, Mathias;
    • Reis, Henning;
    • Welter, Stefan;
    • Eberhardt, Wilfried;
    • Eisenacher, Martin;
    • Teschler, Helmut
    Publication type:
    Article
    22
    23
    24
    25

    Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03842-y
    By:
    • Reimann, Patrick;
    • Mavroeidi, Ilektra-Antonia;
    • Burghofer, Jonathan;
    • Taghizadeh, Hossein;
    • Webersinke, Gerald;
    • Kasper, Stefan;
    • Schreil, Georg;
    • Morariu, Darius;
    • Reichinger, Andreas;
    • Baba, Hideo Andreas;
    • Kirchweger, Patrick;
    • Schuler, Martin;
    • Djanani, Angela;
    • Prager, Gerald W.;
    • Rumpold, Holger;
    • Benda, Magdalena;
    • Schneider, Eva-Maria;
    • Mink, Sylvia;
    • Winder, Thomas;
    • Doleschal, Bernhard
    Publication type:
    Article
    26

    HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4367, doi. 10.1007/s00262-023-03571-8
    By:
    • Kansy, Benjamin A.;
    • Wehrs, Tim P.;
    • Bruderek, Kirsten;
    • Si, Yu;
    • Ludwig, Sonja;
    • Droege, Freya;
    • Hasskamp, Pia;
    • Henkel, Uta;
    • Dominas, Nina;
    • Hoffmann, Thomas K.;
    • Horn, Peter A.;
    • Schuler, Martin;
    • Gauler, Thomas C.;
    • Lindemann, Monika;
    • Lang, Stephan;
    • Bankfalvi, Agnes;
    • Brandau, Sven
    Publication type:
    Article
    27

    Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.

    Published in:
    Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1273, doi. 10.1007/s00262-014-1596-x
    By:
    • Kuehnle, Marie-Cristine;
    • Attig, Sebastian;
    • Britten, Cedrik;
    • Schulze-Bergkamen, Henning;
    • Lordick, Florian;
    • Wichert, Goetz;
    • Thuss-Patience, Peter;
    • Stein, Alexander;
    • Schuler, Martin;
    • Bassermann, Florian;
    • Sahin, Ugur;
    • Türeci, Özlem
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors.

    Published in:
    PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037776
    By:
    • Henze, Joern;
    • Mühlenberg, Thomas;
    • Simon, Susanne;
    • Grabellus, Florian;
    • Rubin, Brian;
    • Taeger, Georg;
    • Schuler, Martin;
    • Treckmann, Juergen;
    • Debiec-Rychter, Maria;
    • Taguchi, Takahiro;
    • Fletcher, Jonathan A.;
    • Bauer, Sebastian
    Publication type:
    Article
    34

    Personalized Treatment for Patients With Lung Cancer.

    Published in:
    Deutsches Ärzteblatt International, 2023, v. 120, n. 17, p. 300, doi. 10.3238/arztebl.m2023.0012
    By:
    • Schuler, Martin;
    • Bölükbas, Servet;
    • Darwiche, Kaid;
    • Theegarten, Dirk;
    • Herrmann, Ken;
    • Stuschke, Martin
    Publication type:
    Article
    35
    36

    Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536.

    Published in:
    Oncology Research & Treatment, 2017, v. 40, n. 7/8, p. 435, doi. 10.1159/000475503
    By:
    • Breitenbuecher, Frank;
    • von Pawel, Joachim;
    • Sebastian, Martin;
    • Kortsik, Cornelius;
    • Ting, Saskia;
    • Kasper, Stefan;
    • Wohlschläger, Jeremias;
    • Worm, Karl;
    • Morresi-Hauf, Alicia;
    • Schad, Arno;
    • Westerwick, Daniela;
    • Wehler, Beatrice;
    • Werner, Martin;
    • Munzert, Gerd;
    • Gaschler-Markefski, Birgit;
    • Schmid, Kurt W.;
    • Schuler, Martin
    Publication type:
    Article
    37
    38

    A phloem‐localized Arabidopsis metacaspase (AtMC3) improves drought tolerance.

    Published in:
    New Phytologist, 2023, v. 239, n. 4, p. 1281, doi. 10.1111/nph.19022
    By:
    • Pitsili, Eugenia;
    • Rodriguez‐Trevino, Ricardo;
    • Ruiz‐Solani, Nerea;
    • Demir, Fatih;
    • Kastanaki, Elizabeth;
    • Dambire, Charlene;
    • de Pedro‐Jové, Roger;
    • Vercammen, Dominique;
    • Salguero‐Linares, Jose;
    • Hall, Hardy;
    • Mantz, Melissa;
    • Schuler, Martin;
    • Tuominen, Hannele;
    • Van Breusegem, Frank;
    • Valls, Marc;
    • Munné‐Bosch, Sergi;
    • Holdsworth, Michael J.;
    • Huesgen, Pitter F.;
    • Rodriguez‐Villalon, Antia;
    • Coll, Nuria S.
    Publication type:
    Article
    39
    40
    41

    A structure‐based fluid biomarker for the differential diagnosis of early‐stage neurodegenerative diseases measured by the immuno‐infrared‐sensor (iRS).

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082847
    By:
    • Schuler, Martin;
    • Mann, Marvin;
    • Langenhoff, Lennart Carl;
    • Budde, Brian;
    • Beyer, Léon;
    • Woitzik, Nathalie;
    • Gerwert, Grischa;
    • Wanka, Robin;
    • Hoeveler, Adrian;
    • Dreier, Max‐Aylmer;
    • Hubert, Diana;
    • Galkowski, Sandy;
    • Güldenhaupt, Jörn;
    • Kötting, Carsten;
    • Gerwert, Klaus Bernhard
    Publication type:
    Article
    42
    43

    The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11046-3
    By:
    • Martens, Uwe M.;
    • Schröder, Jan;
    • Bengsch, Fee;
    • Sellmann, Ludger;
    • Busies, Sabine;
    • Frank-Gleich, Stefanie;
    • Zaiss, Matthias;
    • Decker, Thomas;
    • Schneeweiss, Andreas;
    • Schuler, Martin;
    • Grebhardt, Sina;
    • Zacharias, Stefan;
    • Marschner, Norbert;
    • Kasenda, Benjamin;
    • Potthoff, Karin;
    • Vannier, Corinne
    Publication type:
    Article
    44
    45

    Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.

    Published in:
    2018
    By:
    • Rodon, Jordi;
    • Pérez-Fidalgo, Alejandro;
    • Krop, Ian E.;
    • Burris, Howard;
    • Guerrero-Zotano, Angel;
    • Britten, Carolyn D.;
    • Becerra, Carlos;
    • Schellens, Jan;
    • Richards, Donald A.;
    • Schuler, Martin;
    • Abu-Khalaf, Maysa;
    • Johnson, Faye M.;
    • Ranson, Malcolm;
    • Edenfield, Jeff;
    • Silva, Antonio P.;
    • Hackl, Wolfgang;
    • Quadt, Cornelia;
    • Demanse, David;
    • Duval, Vincent;
    • Baselga, Jose
    Publication type:
    journal article
    46
    47

    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).

    Published in:
    Oncology Research & Treatment, 2023, v. 46, n. 3, p. 89, doi. 10.1159/000529012
    By:
    • Virchow, Isabel;
    • Treckmann, Jürgen-Walter;
    • Prasnikar, Nicole;
    • Linden, Gabriele;
    • Markus, Peter;
    • Schumacher, Brigitte;
    • Albers, David;
    • Herold, Thomas;
    • Ting, Saskia;
    • Schmidt, Hartmut;
    • Radunz, Sonja;
    • Wiesweg, Marcel;
    • Siveke, Jens;
    • Schuler, Martin;
    • Kasper, Stefan
    Publication type:
    Article
    48

    Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.

    Published in:
    Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
    By:
    • Subbiah, Vivek;
    • Hu, Mimi I.;
    • Mansfield, Aaron S.;
    • Taylor, Matthew H.;
    • Schuler, Martin;
    • Zhu, Viola W.;
    • Hadoux, Julien;
    • Curigliano, Giuseppe;
    • Wirth, Lori;
    • Gainor, Justin F.;
    • Alonso, Guzman;
    • Adkins, Douglas;
    • Godbert, Yann;
    • Ahn, Myung-Ju;
    • Cassier, Philippe A.;
    • Cho, Byoung Chul;
    • Lin, Chia-Chi;
    • Zalutskaya, Alena;
    • Barata, Teresa;
    • Trask, Peter
    Publication type:
    Article
    49
    50

    A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02383-5
    By:
    • Chan, Stephen L.;
    • Schuler, Martin;
    • Kang, Yoon-Koo;
    • Yen, Chia-Jui;
    • Edeline, Julien;
    • Choo, Su Pin;
    • Lin, Chia-Chi;
    • Okusaka, Takuji;
    • Weiss, Karl-Heinz;
    • Macarulla, Teresa;
    • Cattan, Stéphane;
    • Blanc, Jean-Frederic;
    • Lee, Kyung-Hun;
    • Maur, Michela;
    • Pant, Shubham;
    • Kudo, Masatoshi;
    • Assenat, Eric;
    • Zhu, Andrew X.;
    • Yau, Thomas;
    • Lim, Ho Yeong
    Publication type:
    Article